Guest guest Posted October 30, 2007 Report Share Posted October 30, 2007 (Cancer Decisions News Staff) Ralph W. Moss, Ph.D. Weekly CancerDecisions.com Newsletter #312 10/28/07 THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER TAXOL DOES NOT HELP PREVENT RECURRENCE OF MOST COMMON BREAST CANCERS - PART ONE In a major setback for the advocates of adjuvant chemotherapy, research published in the New England Journal of Medicine has shown that the widely used drug Taxol (paclitaxel) does not benefit women with the most common form of breast cancer. To read or listen to this week's newsletter, please click here or go to: http://www.cancerdecisions.com/102807.html Thank you. CancerDecisions® PO Box 1076, Lemont, PA 16851 Phone Toll Free: 800-980-1234 | Fax: 814-238-5865 1996-2007 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.